| HGHYX | VGHAX | HGHYX / VGHAX | |
| Total Expense Ratio | 1.05 | 0.27 | 389% |
| Annual Report Gross Expense Ratio | 1.05 | 0.27 | 389% |
| Fund Existence | 26 years | 25 years | - |
| Gain YTD | -0.082 | -4.313 | 2% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 50000 | 500% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 744M | 37B | 2% |
| Annual Yield % from dividends | 0.00 | 1.16 | - |
| Returns for 1 year | 17.25 | 10.17 | 170% |
| Returns for 3 years | 10.71 | -8.81 | -122% |
| Returns for 5 years | -6.68 | -15.78 | 42% |
| Returns for 10 years | 35.39 | -3.38 | -1,047% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ALVDX | 11.23 | 0.09 | +0.81% |
| American Century Focused Lg Cap Val R6 | |||
| WEGRX | 14.86 | 0.11 | +0.75% |
| Allspring Emerging Growth R6 | |||
| VGIAX | 118.33 | 0.62 | +0.53% |
| Vanguard Growth & Income Adm | |||
| FBTDX | 154.06 | 0.78 | +0.51% |
| Franklin Biotechnology Discovery C | |||
| LZUSX | 17.55 | 0.08 | +0.46% |
| Lazard US Equity Focus Instl | |||